Pradhan R, Yin H, Yu O, Azoulay L, et al. Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes. Diabetes Care 2022 Feb 1. pii: 141054. doi: 10.2337/dc21-1953.
PMID: 35104330